Literature DB >> 21480358

Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.

Arnaud Galbois, Vincent Das, Dominique Thabut, Eric Maury, Hafid Ait-Oufella, Chantal Housset, Bertrand Guidet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480358     DOI： 10.1002/hep.24053

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis.

Authors:  Xing-Shun Qi; Ming Bai; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 2.  Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension.

Authors:  Alberto Ferrarese; Alberto Zanetto; Giacomo Germani; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2016-08-28

3.  Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.

Authors:  Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Patrick S Kamath; Heather M Patton; Scott W Biggins; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-12       Impact factor: 11.382

4.  Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2013-06-20       Impact factor: 8.171
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.